Eisai Co., Ltd.
Eisai Co., Ltd. (ESALF) Revenue
Annual & quarterly revenue history · segment & region breakdown
ESALF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsEisai Co., Ltd. trailing twelve-month (TTM) revenue is $831B, an increase of 5.22% year-over-year from $831B in FY2026.
Revenue trend
2026 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $831B | +$41.17B | +5.22% |
| 2025-03-31 | $789B | +$47.65B | +6.42% |
| 2024-03-31 | $742B | -$2.65B | -0.36% |
| 2023-03-31 | $744B | -$11.82B | -1.56% |
| 2022-03-31 | $756B | +$110.28B | +17.07% |
| 2021-03-31 | $646B | -$49.68B | -7.14% |
| 2020-03-31 | $696B | +$52.79B | +8.21% |
| 2019-03-31 | $643B | +$42.78B | +7.13% |
| 2018-03-31 | $600B | +$60.96B | +11.31% |
| 2017-03-31 | $539B | -$8.82B | -1.61% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare ESALF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Eisai Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Eisai Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from Eisai Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ESALF revenue · 4 questionsESALF's trailing twelve-month (TTM) revenue is $831B. That is an increase of 5.22% year-over-year from $831B in FY2026.
▸ Source: FMP · Eisai Co., Ltd. SEC filings · GAAP · Eisai Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026